PharmiWeb Recruiter Blog

As a recruiter or hiring manager in the life science industry, identifying the strongest job candidate requires a comprehensive evaluation of not only hard skills, qualifications, and experiences, but soft skills too.

• Expansion of AZ Forest programme raises commitment to plant 200 million trees across six continents by 2030
• New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia

AstraZeneca has announced a $400 million investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the Company’s climate action, restore nature, promote biodiversity and build ecological and community resilience, spanning over 100,000 hectares worldwide.

Becoming the preferred partner in a challenging economy

INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc. (NASDAQ: DICE) today announced a definitive agreement for Lilly to acquire DICE.

• Vaxxas opens 5,500 square meter (60,000 square feet) state-of-the-art biomedical manufacturing facility in Brisbane, Queensland, which will support the production of millions of Vaxxas’ high-density microarray patches (HD-MAPs) per year for future late-stage clinical trials and first commercial vaccine products.
• Funded by the Queensland Government and Vaxxas, the facility showcases world-class and first-of-a-kind biomedical manufacturing capabilities.
• The facility contains two independent Good Manufacturing Practice (GMP), qualified aseptic cleanrooms, a medical device manufacturing space, a device assembly cleanroom, and supporting infrastructure including laboratories and office space.
• The facility is Vaxxas’ new global headquarters and home to 130 employees including highly-skilled and experienced engineering and scientific experts. The company expects to grow to 200 employees in the next three to five years.
• Vaxxas’ proprietary HD-MAP technology platform has the potential to improve vaccination by creating vaccine products that are easy to use (potentially enabling self-administration) and which can be stable at room temperature, reducing the complexities and costs associated with refrigerated distribution required for many existing vaccines.

CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)-- Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform technology, today announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland. The custom-built 5,500 square meter (60,000 square feet) Vaxxas Biomedical Facility will serve as the company’s global headquarters and support the scale-up of its operations to produce HD-MAP vaccines for future late-stage clinical trials and first commercial products.

Job market returners are individuals who are looking to re-enter the workforce after taking a career break. These individuals can bring significant value to life science organisations as they often possess a wealth of knowledge and expertise gained from previous professional experiences.

Recruiting top talent in the life science industry can be a challenging and costly process. The demand for skilled professionals combined with the specialised nature of the field often leads to high cost-per-hire. However, with careful planning and strategic execution, you can effectively reduce your cost-per-hire whilst still attracting and retaining top talent.

Bagsværd, Denmark, 12 June 2023 - Novo Nordisk today announced plans to invest 15.9 billion Danish kroner starting in 2023¹ to expand an existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio within serious chronic diseases.

The company’s third commercial CAR T manufacturing facility in the U.S. further extends Bristol Myers Squibb’s leadership in cell therapy

In the competitive landscape of life science recruitment, a well-optimised careers page on your company’s website can make all the difference when it comes to presenting your organisation as an employer of choice and attracting top talent.